Authors, year | Sample size, cancer type | Ground truth | Imaging modality | ML classifier | Metric: maximum performance a |
---|---|---|---|---|---|
Bogowicz et al. 2017 [50] | Train: 93, HNSCC Test: 56, HNSCC | p16 | Contrast CT | Logistic regression | Test-AUC: 0.78 |
Buch et al. 2015 [48] | Total: 40, OPSCC | Not reported | Contrast CT | n/a b | n/a b |
Fujita et al. 2016 [49] | Total: 46: non-OPSCC | Not reported | Contrast CT | n/a b | n/a b |
Huang et al. 2019 [51] | Train: 113, HNSCC Test: 53, HNSCC | Train: HPV RNA c Test: p16 | Contrast CT | LASSO-regularized logistic regression | Nested CV-AUC: 0.73 Test-AUC: 0.76 |
Leijenaar et al. 2018 [52] | Train: 628, OPSCC Test:150, OPSCC | p16 | Contrast CT | LASSO-regularized logistic regression | Test-AUC: 0.70–0.80 d |
Mungai et al. 2019 [53] | Total: 50, OPSCC | Not reported | Contrast CT | Logistic regression | n/a e |
Parmar et al. 2015 [54] | Train: 136, OPSCC and LSCC Test:95, OPSCC | Not reported | Contrast CT | Logistic regression | Test-AUC: 0.60 |
Ranjbar et al. 2018 [55] | Total: 107, OPSCC | HPV DNA-ISH | Contrast CT | Diagonal quadratic discriminant analysis | LOOCV-AUC: 0.80 |
Yu et al. 2017 [56] | Train: 150, OPSCC Test:165, OPSCC | p16 | Contrast CT | Logistic regression | CV-AUC: 0.75 test-AUC 1 f: 0.87 test-AUC 2 f: 0.92 |
Zhu et al. 2018 [57] | Total: 126, HNSCC | Not reported | Contrast CT | Random forest | CV-AUC: 0.71 |